References
- Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of alpha-thalassemia mutations in Iran. Haematologica 2007;92(7):992-3
- Neishabury M, Oberkanins C, Moheb LA, et al. High prevalence of the -alpha3.7 deletion among thalassemia patients in Iran. Hemoglobin 2003;27(1):53-5
- Giordano PC, Bakker-Verwij M, Cornelis L. Frequency of globin gene triplications and their interaction with thalassemia mutations. Hemoglobin 2009;33(2):124-31
- Farashi S, Bayat N, Faramarzi garous N, et al. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia. Hemoglobin 2015;39(3):201-6
- Harteveld CL, Refaldi C, Cassinerio E, et al. Segmental duplications involving the α-globin gene cluster are causing β-thalassemia intermedia phenotypes in β-thalassemia heterozygous patients. Blood Cells Mol Dis 2008;40(3):312-16
- Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing a- and b-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet 2005;42(12):922-31
- Ma SK, Au WY, Chan AY, Chan LC. Clinical phenotype of triplicated α-globin genes and heterozygosity for β0-thalassemia in Chinese subjects. Int J Mol Med 2001;8(2):171-5
- Beris P, Solenthaler M, Deutsch S, et al. Severe inclusion body β-thalassaemia with haemolysis in a patient double heterozygous for β0-thalassaemia and quadruplicated α-globin gene arrangement of the anti-4.2 type. Br J Haematol 1999;105(4):1074-80
- Mettananda S, Gibbons R.J, Higgs DR. α-globin as a molecular target in treatment of β-thalassemia. Blood 2015;125(24):3694-701
- Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001;2:245-55
- Wainscoat JS, Kanavakis E, Wood WG, et al. Thalassaemia intermedia in Cyprus: the interaction of α and β thalassaemia. Br J Haematol 1983;53(3):411-16
- Bragós IM, Noguera NI, Raviola MP, et al. Triplication (/αααAnti3.7) or deletion (-α3.7/) association in Argentinian β-thalassemic carriers. Ann Hematol 2003;82(11):696-8
- Quek L, Thein SL. Molecular therapies in beta-thalassaemia. Br J Haematol 2007;136(3):353-65
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215
- Galanello R, Barella S, Turco MP, et al. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. Blood 1994;83(2):561-5
- Wang W, Ma ES, Chan AY, et al. Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 α-globin gene triplications. Clin Chem 2003;49(10):1679-82
- Pornprasert S, Phusua A, Suanta S, et al. Detection of alpha-thalassemia-1 Southeast Asian type using real-time gap-PCR with SYBR Green1 and high resolution melting analysis. Eur J Haematol 2008;80(6):510-14
- Gatta V, Scarciolla O, Gaspari AR, et al. Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet 2005;117(1):92-8
- Gatta V, Antonucci I, Morizio E, et al. Identification and characterization of different SHOX gene deletions in patients with leri-weill dyschondrosteosys by MLPA assay. J Hum Genet 2007;52(1):21-7
- SALSA MLPA probemix P140-B4 HBA, Description version 30; 21-11-2013
- Jiang H, Liu Sh, Zhang YL, et al. Association of an α-globin gene cluster duplication and heterozygous β-thalassemia in a patient with a severe thalassemia syndrome. Hemoglobin 2015;39(2):102-6
- Kimura EM, Grignoli CR, Pinheiro VR, et al. Thalassemia intermedia as a result of heterozygosis for b0-thalassemia and aaaanti-3.7 genotype in a Brazilian patient Braz J Med Biol Res. 2003;36(6):699-701
- Kanavakis E, Metaxotou-Mavromati A, Kattamis C, et al. The triplicated alpha gene locus and beta thalassemia. Br JHaematol 1983;54:201-7
- Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet 2006;9(2):93-7
- Abolghasemi H, Amid A, Zeinali et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007;29(4):233-8